Cargando…

Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group

The objective of this study was to investigate the efficacy and potential side-effects of nucleotide/nucleoside analogues and hepatitis B immunoglobulin injection of newborns in blocking mother-to-child transmission of hepatitis B virus in the middle and late pregnancy period. 238 cases of enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xiaojun, Wang, Chengwei, Wang, Bian, Yang, Xiuzhen, Xu, Hongtao, Shen, Meilong, Zhu, Kuichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759418/ https://www.ncbi.nlm.nih.gov/pubmed/33380780 http://dx.doi.org/10.1155/2020/4305950

Ejemplares similares

Adherence to Nucleoside/Nucleotide Analogue Treatment in Patients with Chronic Hepatitis B
por: Tütüncü, Emin Ediz, et al.
Publicado: (2017)

Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B
por: Lei, Jun, et al.
Publicado: (2013)

Fanconi’s Syndrome and Dementia in a Patient With Chronic Hepatitis B Taking Nucleoside/ Nucleotide Analogue
por: Ho, Cheuk Wah, et al.
Publicado: (2021)

Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues
por: Schreibman, Ian R, et al.
Publicado: (2006)

Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
por: Jang, Tyng-Yuan, et al.
Publicado: (2023)

Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
por: Jang, Tyng-Yuan, et al.
Publicado: (2021)

Adherence to Treatment with Oral Nucleoside/Nucleotide Analogs in Patients with Chronic Hepatitis B
por: Ozyigitoglu, Derya, et al.
Publicado: (2022)

Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B
por: Nagata, Naruhiko, et al.
Publicado: (2016)

Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study
por: Xie, Yiran, et al.
Publicado: (2022)

Effects of Nucleoside Analogue on Patients with Chronic Hepatitis B-Associated Liver Failure: Meta-Analysis
por: Xie, Feng, et al.
Publicado: (2013)

Hepatitis B-Associated Symptomatic Iron Overload, with Complete Resolution after Nucleoside Analogue Treatment
por: Tey, Tze Tong, et al.
Publicado: (2021)

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
por: Lok, Anna S., et al.
Publicado: (2019)

Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother‐to‐child transmission of hepatitis B virus
por: Zhao, Mengyu, et al.
Publicado: (2019)

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
por: Kozielewicz, Dorota, et al.
Publicado: (2015)

An “immune barrier” is formed in the placenta by hepatitis B immunoglobulin to protect the fetus from hepatitis B virus infection from the mother
por: Liu, Jinfeng, et al.
Publicado: (2015)

Outcomes of hepatitis B immunoglobulin and hepatitis B vaccination in high-risk newborns born to HBeAg-positive mothers
por: Wu, Chen-Hsuan, et al.
Publicado: (2022)

A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B
por: Khungar, Vandana, et al.
Publicado: (2010)

Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleoside-Analogue Naive Iranian Patients Treated for Chronic Hepatitis B
por: Bakhshizadeh, Fatemeh, et al.
Publicado: (2015)

Phylogenetic Analysis and Emerging Drug Resistance against Different Nucleoside Analogues in Hepatitis B Virus Positive Patients
por: Gohar, Maryam, et al.
Publicado: (2023)

The Effectiveness of Nucleoside Analogues in Chronic Hepatitis B Patients Unresponsive to Interferon Therapy: Our Clinical Trials for One Year
por: Kose, Sukran, et al.
Publicado: (2010)

Hepatitis B Virus Reactivation with Discontinuation of Nucleoside Analogue in Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation
por: Tsuruoka, Mio, et al.
Publicado: (2021)

Protective Effect of Hepatitis B Vaccine Combined with Two-Dose Hepatitis B Immunoglobulin on Infants Born to HBsAg-Positive Mothers
por: Zou, Huaibin, et al.
Publicado: (2011)

Reversal of Proximal Renal Tubular Dysfunction after Nucleotide Analogue Withdrawal in Chronic Hepatitis B
por: Sobhonslidsuk, Abhasnee, et al.
Publicado: (2017)

Comparing Efficacy of Lamivudine, Adefovir Dipivoxil, Telbivudine, and Entecavir in Treating Nucleoside Analogues Naïve for HBeAg-Negative Hepatitis B with Medium Hepatitis B Virus (HBV) DNA Levels
por: Shi, Hong, et al.
Publicado: (2017)

Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin
por: Qu, Changbo, et al.
Publicado: (2017)

Stable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B Virus
por: Cheng, Xin, et al.
Publicado: (2015)

HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data
por: Kim, Jeong Han, et al.
Publicado: (2013)

Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study
por: Zhou, Jing, et al.
Publicado: (2017)

Quantification and epigenetic evaluation of the residual pool of hepatitis B covalently closed circular DNA in long-term nucleoside analogue-treated patients
por: Lebossé, Fanny, et al.
Publicado: (2020)

Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: A meta‐analysis
por: Lai, Quirino, et al.
Publicado: (2021)

Antenatal administration of hepatitis B immunoglobulin and hepatitis B vaccine to prevent mother to child transmission in hepatitis B virus surface antigen positive pregnant women: A systematic review and meta-analysis
por: Chen, Zhe, et al.
Publicado: (2020)

Hepatitis B Infection, Eastern India
por: Sarkar, Kamalesh, et al.
Publicado: (2004)

Hepatitis B Vaccine and Immunoglobulin: Key Concepts
por: Das, Saibal, et al.
Publicado: (2019)

Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
por: Wang, Peijie, et al.
Publicado: (2014)

Mother-to-child transmission of hepatitis B: extent of knowledge of physicians and midwives in Eastern region of Ghana
por: Adjei, Charles Ampong, et al.
Publicado: (2016)

Synthesis of New Indanyl Nucleoside Analogues and their Biological Evaluation on Hepatitis C Virus (HCV) Replicon
por: Gómez, Matías E., et al.
Publicado: (2019)

Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus‐related hepatocellular carcinoma after surgical resection: A multicenter study
por: Qi, Weili, et al.
Publicado: (2021)

Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus
por: Brayette, Anaïs, et al.
Publicado: (2020)

Low-level viremia in nucleoside analog-treated chronic hepatitis B patients
por: Zhang, Qian, et al.
Publicado: (2021)

Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products
por: Lee, Soyoung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3d2pelheh5tqcm7c9mk6al2g13